|
The Coolest
There are cool new technologies, then there are cool new technologies. This one is the latter. It's called Coolio therapy and was possibly brainstormed by a group of kindergartners because it involves injecting actual ice into peoples' veins.
If it ever gets approved, watch out for shortages - basketball players everywhere will be seeking off-label prescriptions.
Revert!
If your biotech company is named Evolve that could be an acceptable if blasé name. But if your web designer decides to stick a tiny antibody in front of the O, that absolutely does not mean you have to start calling yourself EVQLVE.
Why would you do that? How do we say that? Who are the ad wizards who came up with this? 2/10
What Do
A company may existentially ask itself, what are we? Answers can revolve around their goals, their values, their employees, their country, their favorite color, their height. Or they can do much worse and somehow settle on "We...the source"
A truly visionary statement.
Minimum Rage
Hey, isn't it great when a company shows support for the working people by having an employee of the month? Sure, maybe they only get a Hot 'N' Ready for lunch and a slap on the back, but it shows the bosses care ever so deeply.
Or, instead the company could give employee of the month to a machine, which really gets the troops up and ready to work their tails off.
"Sorry, but your performance has been lacking this month. Please take notes from the example your colleague, High Speed Sorter, has set."
Have Cybertruck, Need Cash
You'd think having a billionaire founder would preclude your company from needing to raise a piddling $43M, yet Neuralink just raised that.
The company has good scientists and engineers and may eventually prove a cutting-edge technology that can do real good for patients, but this outside funding event says quite a lot about the founder's view of the financial upside of such a business, which is frankly, nonexistent.
The heavily regulated healthcare industry is where tech money goes to die and some of those techies do seem to learn their lesson occasionally.
Big Mistake
Not great when your clinical study fails. Not great when it happens shortly after a huge IPO. Not great to later find out the clinical trial was messed up by your contractor.
Acelyrin recently made that shocking clinical trial snafu announcement.
We are cynics (could you tell?) and assumed this PR was a ploy to juice the stock price, but it dropped 18% after the release. Guess fears of ineptitude won out over a slight improvement in approval hopes.
Got Us
CiRC Biosciences is working on new therapies for retinal diseases in the hopes of restoring vision loss. To do this they are attempting to convert fibroblasts into what they term CiPCs.
So, you could imagine our delight when we navigated to their pipeline page and saw this.
Turns out it's a browser-specific issue - the image is indeed clear on most platforms. But for a bit it seemed like a truly delightful troll job.
Team Roasting in the Sun
As Co-Founder & Board Chair you do have a role to play at a company, but you're not all that important. So, not much reason to flex in your company profile. And it's certainly uncalled for to casually list your hobby as "relaxing on my island", you son of a beach.
| 
